Glancy Prongay & Murray
Tracked across 5 events · 154 articles · First seen Mar 31, 2026 · Last active May 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Gossamer Bio is facing multiple securities class action lawsuits following the announcement on February 23, 2026, that its Phase 3 PROSERA study for seralutinib, a treatment for pulmonary arterial hypertension, failed to meet its primary…
Impact: Glancy Prongay & Murray is a shareholder rights law firm that has commenced an investigation and is encouraging investors of Gossamer Bio to inquire about potentially pursuing claims.
Apr 01, 2026 · 103 articles
Business
Lufax Holding is facing a securities fraud class action lawsuit filed by multiple law firms, including Bernstein Liebhard LLP, Rosen Law Firm, Glancy Prongay & Murray, and The Gross Law Firm. The lawsuit alleges that…
Impact: Glancy Prongay & Murray reminds investors of the upcoming deadline to file a lead plaintiff motion in the class action against Lufax Holding.
Apr 02, 2026 · 32 articles
Business
Coty is facing a securities fraud class action lawsuit, with law firms like The Law Offices of Frank R. Cruz and Glancy Prongay & Murray LLP announcing opportunities for investors to participate. The lawsuit alleges…
Impact: Glancy Prongay & Murray LLP is another law firm announcing the opportunity for investors to lead the securities fraud class action lawsuit against Coty.
May 01, 2026 · 7 articles
Business
A securities fraud class action lawsuit has been initiated against Stellantis N.V. by law firms including the The Law Offices of Frank R. Cruz and Glancy Prongay & Murray. The lawsuit alleges that Stellantis made…
Impact: Glancy Prongay & Murray is also inviting investors to participate in the securities fraud lawsuit against Stellantis.
May 01, 2026 · 6 articles
Business
Multiple law firms, including the Law Offices of Howard G. Smith, the The Law Offices of Frank R. Cruz, and Glancy Prongay & Murray LLP, have announced opportunities for investors to lead a securities fraud…
Impact: Glancy Prongay & Murray LLP is also announcing the opportunity for investors to lead the securities fraud class action lawsuit against Atara Biotherapeutics.
May 01, 2026 · 6 articles
90
Glancy Prongay & Murray announced lawsuit opportunity CotyCoty Securities Fraud...
90
Glancy Prongay & Murray invited investors StellantisStellantis Securities Fraud Lawsuit
80
Glancy Prongay & Murray commenced investigation Gossamer BioGossamer Bio PROSERA Study...
80
Glancy Prongay & Murray announced lawsuit opportunity Atara BiotherapeuticsAtara Biotherapeutics...
70
Glancy Prongay & Murray filed class action Lufax HoldingLufax Holding Securities...
NEWSDESK
Track Glancy Prongay & Murray live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard